Literature DB >> 26493305

Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.

Luca Donazzan1,2, Felix Mahfoud1, Sebastian Ewen1, Christian Ukena1, Bodo Cremers1, Carl-Martin Kirsch3, Dirk Hellwig3,4, Tareq Eweiwi3, Samer Ezziddin3, Murray Esler5, Michael Böhm6.   

Abstract

OBJECTIVES: To investigate, whether renal denervation (RDN) has a direct effect on cardiac sympathetic activity and innervation density.
BACKGROUND: RDN demonstrated its efficacy not only in reducing blood pressure (BP) in certain patients, but also in decreasing cardiac hypertrophy and arrhythmias. These pleiotropic effects occur partly independent from the observed BP reduction.
METHODS: Eleven patients with resistant hypertension (mean office systolic BP 180 ± 18 mmHg, mean antihypertensive medications 6.0 ± 1.5) underwent I-123-mIBG scintigraphy to exclude pheochromocytoma. We measured cardiac sympathetic innervation and activity before and 9 months after RDN. Cardiac sympathetic innervation was assessed by heart to mediastinum ratio (H/M) and sympathetic activity by wash out ratio (WOR). Effects on office BP, 24 h ambulatory BP monitoring, were documented.
RESULTS: Office systolic BP and mean ambulatory systolic BP were significantly reduced from 180 to 141 mmHg (p = 0.006) and from 149 to 129 mmHg (p = 0.014), respectively. Cardiac innervation remained unchanged before and after RDN (H/M 2.5 ± 0.5 versus 2.6 ± 0.4, p = 0.285). Cardiac sympathetic activity was significantly reduced by 67 % (WOR decreased from 24.1 ± 12.7 to 7.9 ± 25.3 %, p = 0.047). Both, responders and non-responders experienced a reduction of cardiac sympathetic activity.
CONCLUSION: RDN significantly reduced cardiac sympathetic activity thereby demonstrating a direct effect on the heart. These changes occurred independently from BP effects and provide a pathophysiological basis for studies, investigating the potential effect of RDN on arrhythmias and heart failure.

Entities:  

Keywords:  Arrhythmias; Heart failure; MIBG; Renal denervation; Resistant hypertension

Mesh:

Substances:

Year:  2015        PMID: 26493305     DOI: 10.1007/s00392-015-0930-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  40 in total

Review 1.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

2.  Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation.

Authors:  Tara Bourke; Marmar Vaseghi; Yoav Michowitz; Vineet Sankhla; Mandar Shah; Nalla Swapna; Noel G Boyle; Aman Mahajan; Calambur Narasimhan; Yash Lokhandwala; Kalyanam Shivkumar
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

3.  Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.

Authors:  Stephan H Schirmer; Marwa M Y A Sayed; Jan-Christian Reil; Daniel Lavall; Christian Ukena; Dominik Linz; Felix Mahfoud; Michael Böhm
Journal:  JACC Cardiovasc Interv       Date:  2015-05-20       Impact factor: 11.195

4.  Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study.

Authors:  H Ogita; T Shimonagata; M Fukunami; K Kumagai; T Yamada; Y Asano; A Hirata; M Asai; H Kusuoka; M Hori; N Hoki
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

5.  Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.

Authors:  Dagmara Hering; Petra Marusic; Antony S Walton; Elisabeth A Lambert; Henry Krum; Krzysztof Narkiewicz; Gavin W Lambert; Murray D Esler; Markus P Schlaich
Journal:  Hypertension       Date:  2014-04-14       Impact factor: 10.190

6.  Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy.

Authors:  Benjamin F Remo; Mark Preminger; Jason Bradfield; Suneet Mittal; Noel Boyle; Anuj Gupta; Kalyanam Shivkumar; Jonathan S Steinberg; Timm Dickfeld
Journal:  Heart Rhythm       Date:  2013-12-31       Impact factor: 6.343

7.  Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.

Authors:  K Sakata; M Shirotani; H Yoshida; R Nawada; K Obayashi; K Togi; N Miho
Journal:  Hypertension       Date:  1999-06       Impact factor: 10.190

8.  6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias.

Authors:  Luciana V Armaganijan; Rodolfo Staico; Dalmo A R Moreira; Renato D Lopes; Paulo T J Medeiros; Ricardo Habib; Jônatas Melo Neto; Marcelo Katz; Dikran Armaganijan; Amanda G M R Sousa; Felix Mahfoud; Alexandre Abizaid
Journal:  JACC Cardiovasc Interv       Date:  2015-06       Impact factor: 11.195

9.  Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation.

Authors:  Dominik Linz; Felix Mahfoud; Ulrich Schotten; Christian Ukena; Mathias Hohl; Hans-Ruprecht Neuberger; Klaus Wirth; Michael Böhm
Journal:  Hypertension       Date:  2012-11-12       Impact factor: 10.190

Review 10.  Cardiac autonomic imaging with SPECT tracers.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

View more
  25 in total

Review 1.  Hypertension: history and development of established and novel treatments.

Authors:  Milan Wolf; Sebastian Ewen; Felix Mahfoud; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-06-27       Impact factor: 5.460

2.  123I-mIBG scintigraphy: Clinical tool for assessing renal sympathetic activity?

Authors:  Christopher George; Pradeep G Bhambhvani; Suzanne Oparil
Journal:  J Nucl Cardiol       Date:  2016-12-30       Impact factor: 5.952

3.  Patient preference for therapies in hypertension: a cross-sectional survey of German patients.

Authors:  Roland E Schmieder; Karin Högerl; Susanne Jung; Peter Bramlage; Roland Veelken; Christian Ott
Journal:  Clin Res Cardiol       Date:  2019-04-02       Impact factor: 5.460

Review 4.  Modulation of renal sympathetic innervation: recent insights beyond blood pressure control.

Authors:  Dominik Linz; Mathias Hohl; Adrian D Elliott; Dennis H Lau; Felix Mahfoud; Murray D Esler; Prashanthan Sanders; Michael Böhm
Journal:  Clin Auton Res       Date:  2018-02-10       Impact factor: 4.435

5.  Second denervation in a patient with resistant hypertension.

Authors:  Jose Carlos Prado; Dayan Salado; Luis Miguel Ruilope; Julian Segura
Journal:  Clin Res Cardiol       Date:  2016-06-08       Impact factor: 5.460

6.  Flow-mediated dilation, nitroglycerin-mediated dilation and their ratio predict successful renal denervation in mild resistant hypertension.

Authors:  Martin Steinmetz; Dominik Nelles; Jutta Weisser-Thomas; Christian Schaefer; Georg Nickenig; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2018-04-11       Impact factor: 5.460

7.  Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.

Authors:  Karl Fengler; Diana Heinemann; Thomas Okon; Karoline Röhnert; Thomas Stiermaier; Maximilian von Röder; Christian Besler; Ulrike Müller; Robert Höllriegel; Gerhard Schuler; Steffen Desch; Philipp Lurz
Journal:  Clin Res Cardiol       Date:  2016-01-04       Impact factor: 5.460

Review 8.  Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.

Authors:  Karl Fengler; Karl Philipp Rommel; Thomas Okon; Gerhard Schuler; Philipp Lurz
Journal:  World J Cardiol       Date:  2016-08-26

9.  Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry.

Authors:  Christian Ukena; Felix Mahfoud; Sebastian Ewen; Andreas Bollmann; Gerhard Hindricks; Boris A Hoffmann; Dominik Linz; Dan Musat; Valerie Pavlicek; Eberhard Scholz; Dierk Thomas; Stephan Willems; Michael Böhm; Jonathan S Steinberg
Journal:  Clin Res Cardiol       Date:  2016-06-30       Impact factor: 5.460

Review 10.  Heart failure with preserved ejection fraction based on aging and comorbidities.

Authors:  Ying Lin; Shihui Fu; Yao Yao; Yulong Li; Yali Zhao; Leiming Luo
Journal:  J Transl Med       Date:  2021-07-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.